ArticleEndocrine, metabolic & immune disorders drug targets2024

Case Report: Opposite Tumoral and Hormonal Responses to Low-dose Pasireotide in Cushing's Disease.

Andreea Liliana Serban et al.PubMed ↗Publisher ↗

No numbers read from the abstract.